BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 3404264)

  • 21. Fluorine-18 labeling of proteins.
    Kilbourn MR; Dence CS; Welch MJ; Mathias CJ
    J Nucl Med; 1987 Apr; 28(4):462-70. PubMed ID: 3494825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced glycated human serum albumin as AGE-carrier protein in enzyme-linked immunosorbent assay.
    Benko B; Turk Z
    Clin Lab; 2008; 54(9-10):331-9. PubMed ID: 19097490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on relationship between hemocompatibility and protein adsorption for DLC].
    Li B; Yin G; Kang Y; Zheng C; He X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Dec; 19(4):547-51. PubMed ID: 12561343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
    Giesel FL; von Tengg-Kobligk H; Wilkinson ID; Siegler P; von der Lieth CW; Frank M; Lodemann KP; Essig M
    Invest Radiol; 2006 Mar; 41(3):222-8. PubMed ID: 16481904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
    Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression, refolding, and isotopic labeling of human serum albumin domains for NMR spectroscopy.
    Mao H; Gunasekera AH; Fesik SW
    Protein Expr Purif; 2000 Dec; 20(3):492-9. PubMed ID: 11087689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability, targeting, and biodistribution of scandium-46- and gallium-67-labeled monoclonal antibody in erythroleukemic mice.
    Anderson WT; Strand M
    Cancer Res; 1985 May; 45(5):2154-8. PubMed ID: 3857116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 68Ga-labeled oligonucleotides for in vivo imaging with PET.
    Roivainen A; Tolvanen T; Salomäki S; Lendvai G; Velikyan I; Numminen P; Välilä M; Sipilä H; Bergström M; Härkönen P; Lönnberg H; Långström B
    J Nucl Med; 2004 Feb; 45(2):347-55. PubMed ID: 14960659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of photoactivation in the preparation of radiopharmaceuticals. III. Human serum albumin labelled with technetium (99mTc)].
    Komárek P; Kleisner I; Konopková M; Komárková I
    Ceska Slov Farm; 1997 Oct; 46(5):217-21. PubMed ID: 9600144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Succinylated polylysine as a possible link between an antibody molecule and deferoxamine.
    Slinkin MA; Klibanov AL; Khaw BA; Torchilin VP
    Bioconjug Chem; 1990; 1(4):291-5. PubMed ID: 2096922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of the metabolite N-hydroxy-desferrioxamine B.
    Roggo BE; Peter HH
    J Antibiot (Tokyo); 1993 Feb; 46(2):294-9. PubMed ID: 8468245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stable labelling of serum albumin microspheres with gallium-68.
    Maziere B; Loc'h C; Steinling M; Comar D
    Int J Rad Appl Instrum A; 1986; 37(4):360-1. PubMed ID: 3021659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of the distribution of desferrioxamine in the isolated perfused rabbit kidney.
    Toffa S; Cheetham K; Fuller B; Gower J; Green C
    Biochem Soc Trans; 1991 Apr; 19(2):217S. PubMed ID: 1889591
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis and comparative biodistribution of the desferrioxamine-human serum albumin (DF-HSA) conjugates prepared with various methods.
    Jánoki GA; Harwig JF; Wolf W
    J Nucl Med Allied Sci; 1988; 32(1):39-44. PubMed ID: 3404264
    [No Abstract]   [Full Text] [Related]  

  • 35. Gallium-labeled deferoxamine-galactosyl-neoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistry.
    Vera DR
    J Nucl Med; 1992 Jun; 33(6):1160-6. PubMed ID: 1597732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deferoxamine, a promising bifunctional chelating agent for labeling proteins with gallium: Ga-67 DF-HSA: concise communication.
    Yokoyama A; Ohmomo Y; Horiuchi K; Saji H; Tanaka H; Yamamoto K; Ishii Y; Torizuka K
    J Nucl Med; 1982 Oct; 23(10):909-14. PubMed ID: 7119886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An approach for immunoradiometric assay with metallic radionuclides: gallium-67-deferoxamine-dialdehyde starch-IgG.
    Furukawa T; Fujibayashi Y; Fukunaga M; Saga T; Endo K; Yokoyama A
    J Nucl Med; 1991 May; 32(5):825-9. PubMed ID: 2022990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, pharmacokinetics, and biodistribution of 67GA deferoxamineacetyl-cysteinylbiotin.
    Hashmi M; Rosebrough SF
    Drug Metab Dispos; 1995 Dec; 23(12):1362-7. PubMed ID: 8689944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Methods of leukocyte radionuclide labeling and the potentials for using labelled leukocytes in medicine].
    Vorob'eva EN
    Med Radiol (Mosk); 1981 Nov; 26(11):81-6. PubMed ID: 7033713
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.